tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Organogenesis Holdings Inc

ORGO
Add to Watchlist
2.370USD
-0.080-3.27%
Close 07-31 16:00（ET）Quotes delayed by 15 min
304.96MMarket Cap
LossP/E TTM

Organogenesis Holdings Inc

2.370
-0.080-3.27%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ORGO Financials

See Organogenesis Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Organogenesis Holdings Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.35
Revenue / Forecast
--/54.25M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
564.17M
17.04%
EPS(YoY)
0.16
2318.82%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-157.04%-0.44
510.77%0.28
23.08%0.11
25.18%-0.10
-973.20%-0.17
1158.64%0.05
285.61%0.09
-417.51%-0.13
29.67%-0.02
-107.49%0.00
--0.02
--0.04
---0.02
--0.06
--0.06
----
----
----
----
----
Revenue
-57.06%37.23M
78.13%225.61M
30.98%150.86M
-22.44%101.00M
-21.17%86.69M
27.10%126.66M
6.12%115.18M
11.01%130.23M
2.17%109.98M
-13.73%99.65M
-7.13%108.53M
-3.36%117.32M
10.84%107.64M
-10.14%115.52M
2.73%116.86M
-1.46%121.40M
-5.30%97.12M
20.36%128.56M
12.85%113.75M
78.65%123.20M
Net Profit
-160.10%-56.16M
497.82%35.12M
17.79%14.53M
28.40%-12.20M
-928.14%-21.59M
1134.33%5.88M
289.36%12.33M
-420.60%-17.04M
29.27%-2.10M
-107.59%-568.00K
1373.02%3.17M
-39.20%5.32M
-225.19%-2.97M
-85.52%7.49M
-98.29%215.00K
-57.73%8.74M
-109.18%-913.00K
190.76%51.70M
-39.92%12.58M
500.45%20.69M
Net Margin
-556.93%-142.78%
219.73%19.37%
33.53%14.30%
28.95%-9.30%
-1038.27%-21.74%
1162.85%6.06%
266.89%10.71%
-388.80%-13.09%
30.77%-1.91%
-108.80%-0.57%
--2.92%
--4.53%
---2.76%
--6.48%
--2.40%
----
----
----
----
----
Gross Margin
-57.63%30.77%
3.17%77.87%
-1.00%75.97%
-6.36%72.64%
-1.72%72.64%
4.64%75.48%
0.65%76.73%
0.02%77.58%
-1.83%73.91%
-5.75%72.13%
--76.24%
--77.57%
--75.28%
--76.53%
--76.77%
----
----
----
----
----
Debt to assets ratio
620.98%2.47%
878.82%3.71%
-95.50%0.65%
-98.08%0.29%
-97.67%0.34%
-97.48%0.38%
-6.06%14.40%
-3.72%14.88%
-5.90%14.74%
-4.48%15.04%
--15.33%
--15.45%
--15.66%
--15.75%
--15.88%
----
----
----
----
----
Income Statement
Revenue
-57.06%37.23M
78.13%225.61M
30.98%150.86M
-22.44%101.00M
-21.17%86.69M
27.10%126.66M
6.12%115.18M
11.01%130.23M
2.17%109.98M
-13.73%99.65M
-7.13%108.53M
-3.36%117.32M
10.84%107.64M
-10.14%115.52M
2.73%116.86M
-1.46%121.40M
-5.30%97.12M
20.36%128.56M
12.85%113.75M
78.65%123.20M
Operating profit
-197.88%-60.11M
634.83%75.09M
246.83%21.65M
-221.56%-10.83M
-423.86%-20.18M
304.39%10.22M
-35.97%6.24M
-7.38%8.91M
-84.04%-3.85M
-73.31%2.53M
307.91%9.75M
-23.53%9.62M
-1638.97%-2.09M
-57.50%9.47M
-86.16%2.39M
-48.72%12.58M
-99.00%136.00K
2.79%22.28M
-24.83%17.27M
1189.08%24.53M
Net Profit
-160.10%-56.16M
497.82%35.12M
17.79%14.53M
28.40%-12.20M
-928.14%-21.59M
1134.33%5.88M
289.36%12.33M
-420.60%-17.04M
29.27%-2.10M
-107.59%-568.00K
1373.02%3.17M
-39.20%5.32M
-225.19%-2.97M
-85.52%7.49M
-98.29%215.00K
-57.73%8.74M
-109.18%-913.00K
190.76%51.70M
-39.92%12.58M
500.45%20.69M
Balance Sheet
Current assets
0.13%268.50M
26.67%362.19M
25.68%299.75M
11.11%260.22M
18.05%268.16M
27.06%285.94M
5.73%238.51M
8.21%234.19M
4.77%227.17M
1.09%225.04M
-2.15%225.57M
-6.52%216.44M
-0.47%216.82M
-1.93%222.61M
8.82%230.53M
14.76%231.54M
17.61%217.85M
30.19%226.98M
64.20%211.84M
71.41%201.76M
Total current liabilities
16.86%76.02M
29.23%100.12M
16.87%90.32M
-23.20%65.84M
-21.43%65.05M
-3.77%77.48M
-5.16%77.28M
16.71%85.73M
8.84%82.80M
7.31%80.51M
-8.73%81.48M
-16.75%73.45M
-0.93%76.08M
-8.51%75.02M
10.21%89.27M
4.36%88.23M
3.76%76.79M
20.21%82.00M
22.27%81.00M
27.99%84.55M
Total assets
11.25%519.99M
20.25%598.73M
14.24%509.83M
4.05%461.13M
1.94%467.39M
8.23%497.89M
-3.53%446.30M
-1.59%443.16M
2.77%458.48M
2.37%460.02M
1.18%462.65M
-1.32%450.31M
2.25%446.11M
1.38%449.36M
23.45%457.27M
28.35%456.36M
36.68%436.27M
50.52%443.26M
50.32%370.42M
64.24%355.56M
Total liabilities
39.59%138.65M
46.41%164.81M
-26.17%123.85M
-44.39%99.91M
-44.96%99.33M
-37.93%112.57M
-9.71%167.75M
0.35%179.66M
-1.07%180.45M
-1.27%181.36M
-7.55%185.78M
-11.36%179.03M
-5.51%182.41M
-8.71%183.69M
10.87%200.94M
14.34%201.97M
19.24%193.04M
35.59%201.22M
0.16%181.25M
-2.27%176.64M
Total equity
3.61%381.35M
12.61%433.92M
38.57%385.98M
37.08%361.22M
32.38%368.07M
38.27%385.32M
0.61%278.55M
-2.87%263.50M
5.43%278.03M
4.89%278.66M
8.01%276.87M
6.64%271.28M
8.42%263.70M
9.76%265.67M
35.50%256.33M
42.18%254.38M
54.63%243.23M
65.68%242.03M
188.93%189.17M
400.48%178.92M
Cash Flow Statement
Net operating income
205.98%21.13M
260.43%39.42M
-64.59%3.08M
-793.82%-32.87M
-96.17%-19.93M
3.04%10.94M
-48.04%8.70M
-45.20%4.74M
-100.16%-10.16M
36.08%10.61M
206.88%16.73M
-15.19%8.65M
-459.82%-5.08M
-56.54%7.80M
-80.42%5.45M
-42.27%10.20M
208.54%1.41M
-28.04%17.95M
289.89%27.85M
289.17%17.66M
Net investment
13.24%-3.15M
-38.41%-4.65M
13.00%-2.23M
-93.51%-3.64M
-63.19%-3.63M
-1.11%-3.36M
57.03%-2.57M
74.93%-1.88M
70.62%-2.22M
68.81%-3.32M
42.52%-5.98M
-21.58%-7.50M
-13.34%-7.56M
-103.86%-10.66M
37.72%-10.40M
-36.70%-6.17M
-34.60%-6.67M
26.83%-5.23M
-63.18%-16.70M
-140.64%-4.51M
Net financing
-883.12%-20.21M
-114.29%-4.81M
-508.65%-10.21M
83.32%-288.00K
21.17%-2.06M
1993.58%33.65M
-16.62%-1.68M
-63.85%-1.73M
-111.00%-2.61M
5.23%-1.78M
-5630.77%-1.44M
-353.98%-1.05M
-61.57%-1.24M
-104.47%-1.88M
-97.95%26.00K
152.01%415.00K
-29.44%-765.00K
-103.04%-917.00K
263.87%1.27M
-116.32%-798.00K

FAQs

What is the total revenue of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its total revenue reached 564.17M, with a year-on-year change of 482.04M.

What are the current assets of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its current assets were 362.19M, with a year-on-year change of 26.67.

What are the total assets of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its total assets of Organogenesis Holdings Inc were 598.73M, with a year-on-year change of 20.25.

What are the total liabilities of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its total liabilities of Organogenesis Holdings Inc were 164.81M, with a year-on-year change of 46.41.

What is the total equity of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its total equity of Organogenesis Holdings Inc was 433.92M, with a year-on-year change of 12.61.

What is the net operating income of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its net operating income of Organogenesis Holdings Inc was 66.25M, with a year-on-year change of 207.87.

What is the net investment of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its net investment of Organogenesis Holdings Inc was -14.15M, with a year-on-year change of -41.06.

What is the net financing of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its net financing of Organogenesis Holdings Inc was -17.36M, with a year-on-year change of -162.81.

What is the Earnings Per Share (EPS) of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.16, with a year-on-year change of 2318.82.

What is the net income of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its net income was 20.02M, with a year-on-year change of 2236.82.

What is the net margin of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its net profit margin was 6.56, with a year-on-year change of 3575.04.

What is the gross margin of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its gross margin was 75.62, with a year-on-year change of -0.48.

What is the debt-to-asset ratio of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 3.71, with a year-on-year change of 878.82.

What is the Return on Equity (ROE) of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was 7.11, with a year-on-year change of 2155.35.

What is the Return on Assets (ROA) of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was 6.75, with a year-on-year change of 3657.03.

What is the operating profit of Organogenesis Holdings Inc?

According to Organogenesis Holdings Inc's FY2025 earnings report, its operating profit was 66.25M, with a year-on-year change of 207.87.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy